Publikationen

2023

  • Amin T, Viol F, Krause J, Fahl M, Eggers C, Awwad F, Schmidt B, Benten D, Ungefroren H, Fraune C, Clauditz TS, Sauter G, Izbicki JR, Lohse AW, Huber S, Schrader J. Cancer-Associated Fibroblasts Induce Proliferation and Therapeutic Resistance to Everolimus in Neuroendocrine Tumors through STAT3 Activation. Neuroendocrinology. 2023;113(5):501-518. doi: 10.1159/000528539. Epub 2022 Dec 6. PMID: 36473454. (IF 4.27)

  • Schmidt BC, Leiderer MT, Amin T, Viol F, Huber S, Henes FO, Schrader J. Does gamma-glutamyltransferase correlate with liver tumor burden in neuroendocrine tumors? Endocrine. 2023 Sep 28. doi: 10.1007/s12020-023-03545-x. Epub ahead of print. PMID: 37770647. (IF 3.88)

  • Panzuto F, Ramage J, Pritchard DM, van Velthuysen MF, Schrader J, Begum N, Sundin A, Falconi M, O'Toole D. European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3. J Neuroendocrinol. 2023 Aug;35(8):e13306. doi: 10.1111/jne.13306. Epub 2023 Jul 4. PMID: 37401795. (IF 4.27)

2022

  • Awwad F, Ozga AK, Amin T, Schlueter C, Kailani S, Perez D, Wolter S, Sauter G, Izbicki J, Lohse AW, Schrader J. Metabolic Syndrome Is Associated with Impaired Survival after Surgery for Pancreatic Neuroendocrine Tumors. Neuroendocrinology. 2022;112(12):1225-1236. doi: 10.1159/000524366. Epub 2022 Mar 30. PMID: 35354139. (IF 4.27)

  • Viol F, Sipos B, Fahl M, Clauditz TS, Amin T, Kriegs M, Nieser M, Izbicki JR, Huber S, Lohse AW, Schrader J. Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy. Cell Oncol (Dordr). 2022 Dec;45(6):1401-1419. doi: 10.1007/s13402-022-00727-z. Epub 2022 Oct 21. PMID: 36269546; PMCID: PMC9747820. (IF 6.31)

  • Krug S, Khosravian M, Weissbach J, George K, Damm M, Garbe J, Walldorf J, Reuken PA, Amin T, Siebenhüner A, Rosendahl J, Gress TM, Michl P, Schrader J, Rinke A. The Patient's Point of View: COVID-19 and Neuroendocrine Tumor Disease. Cancers (Basel). 2022 Jan 26;14(3):613. doi: 10.3390/cancers14030613. PMID: 35158882; PMCID: PMC8833713. (IF 6.7)

  • Ungefroren H, Künstner A, Busch H, Franzenburg S, Luley K, Viol F, Schrader J, Konukiewitz B, Wellner UF, Meyhöfer SM, Keck T, Marquardt JU, Lehnert H. Differential Effects of Somatostatin, Octreotide, and Lanreotide on Neuroendocrine Differentiation and Proliferation in Established and Primary NET Cell Lines: Possible Crosstalk with TGF-β Signaling. Int J Mol Sci. 2022 Dec 14;23(24):15868. doi: 10.3390/ijms232415868. PMID: 36555512; PMCID: PMC9781720. (IF 5.6)

  • Fraune C, Simon R, Hube-Magg C, Makrypidi-Fraune G, Kluth M, Büscheck F, Amin T, Viol F, Fehrle W, Dum D, Höflmayer D, Burandt E, Clauditz TS, Perez D, Izbicki J, Wilczak W, Sauter G, Steurer S, Schrader J. Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine Carcinomas. Endocr Pathol. 2020 Jun;31(2):182-189. doi: 10.1007/s12022-020-09612-7. PMID: 32144630; PMCID: PMC7250944. (IF 4.23)

  • Nießen A, Schimmack S, Lewosinska M, Hinz U, Bechtiger FA, Hackert T, Büchler MW, Strobel O. Lymph node metastases and recurrence in pancreatic neuroendocrine neoplasms. Surgery. 2022 Dec;172(6):1791-1799. doi: 10.1016/j.surg.2022.08.020. Epub 2022 Sep 28. PMID: 36180252. (IF 4.3)

  • Nießen A, Schimmack S, Billmann F, Hackert T. Chirurgie bei neuroendokrinen Neoplasien des Pankreas: State of the Art [Surgery of pancreatic neuroendocrine neoplasms: state of the art]. Chirurgie (Heidelb). 2022 Aug;93(8):745-750. German. doi: 10.1007/s00104-022-01641-8. Epub 2022 May 2. PMID: 35499762. (IF 0.9)

  • Billmann F, Nießen A, Hackert T. Stellenwert der Chirurgie bei fernmetastasierten neuroendokrinen Neoplasien des Pankreas [Importance of surgery in distant metastatic pancreatic neuroendocrine neoplasms]. Chirurgie (Heidelb). 2022 Aug;93(8):758-764. German. doi: 10.1007/s00104-022-01630-x. Epub 2022 Apr 11. PMID: 35403909. (IF 0.9)

  • Nießen A, Bechtiger FA, Hinz U, Lewosinska M, Billmann F, Hackert T, Büchler MW, Schimmack S. Enucleation Is a Feasible Procedure for Well-Differentiated pNEN-A Matched Pair Analysis. Cancers (Basel). 2022 May 23;14(10):2570. doi:10.3390/cancers14102570. PMID: 35626174; PMCID: PMC9139922. (IF 6.5)

  • He L, Boulant S, Stanifer M, Guo C, Nießen A, Chen M, Felix K, Bergmann F, Strobel O, Schimmack S. The link between menin and pleiotrophin in the tumor biology of pancreatic neuroendocrine neoplasms. Cancer Sci. 2022 May;113(5):1575-1586. doi: 10.1111/cas.15301. Epub 2022 Mar 8. PMID: 35179814; PMCID: PMC9128182. (IF 6.7)